We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Dietary Supplement Trade Group Disputes Study On Heart Benefits Of Omega-3s

April 9, 2012: 10:52 PM EST
A dietary supplement industry trade group has issued a statement disputing the findings of a recent study that said there wasn’t enough evidence that omega-3 fatty acid supplements improve cardiovascular health in heart patients. The Natural Products Association (NPA) pointed to a “wealth of evidence” from epidemiological and observational studies showing that omega-3 fatty acids are beneficial for heart disease. According to the NPA, two studies in particular – the GISSI-Prevenzione trial and the Japan EPA Lipid Intervention study – showed that omega-3 supplements reduced the risk of death, nonfatal myocardial infarction and nonfatal stroke.
Mike Keaton, "NPA Expert Says Study on Omega-3 Supplements and Cardiovascular Disease “Limited” and “Inaccurate”", Press release, Natural Products Association (NPA), April 09, 2012, © Natural Products Association (NPA)
Diet Insights
Diet Research & Advice
North America
United States of America
Companies, Organizations
Market News
Research, Studies, Advice
Developed by Yuri Ingultsov Software Lab.